Sanofi Pasteur: the world’s leading vaccine specialist
Sanofi Pasteur, the vaccines division of sanofi-aventis Group,is the largest company in the world devoted entirely to human vaccines.
In 2010, Sanofi Pasteur distributed more than1 billion doses of vaccines, making it possible to vaccinate more than 500 million people across the globe.
The company offers the broadest range of vaccines, providing protection against 20 diseases:
bacterial diseases: cholera, diphtheria, Haemophilus influenzae type b infections, meningococcal meningitis (serogroups A, C, Y and W-135), pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, viral diseases: chickenpox, hepatitis A, hepatitis B, influenza, Japanese encephalitis, measles, mumps, poliomyelitis, rabies, rubella and yellow fever.
A Global Operation
Sanofi Pasteur has twelve production and/or R&D sites located in Marcy l'Etoile and Val de Reuil, France; in Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), Orlando (Florida) and Rockville (Maryland), USA; in Toronto, Canada; in Pilar, Argentina; in Shenzhen, China; in Hyderabad, India and in Chachoengsao, Thailand. Three new facilities under construction in Ocoyoacac, Mexico ; Neuville, France ; and Shenzhen, China.
In Europe, Sanofi Pasteur MSD, a joint venture with Merck & Co., develops and distributes vaccines in 19 countries in Europe: Germany, Austria, Belgium, Denmark, Spain, Finland, France, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Norway, Netherlands, Portugal, United Kingdom, Sweden, Switzerland.